Northrop Grumman CORP /DE/ Form 4 insider transactions

Marianne Catherine Brown, a director of Northrop Grumman, acquired 385 shares of common stock through the company's Long-Term Incentive Stock Plan.

Director David P. Abney acquired 385 shares of Northrop Grumman common stock through a deferred stock unit account under the company's Long-Term Incentive Stock Plan.

Director Mary A. Winston acquired shares of Northrop Grumman common stock through the company's Long-Term Incentive Stock Plan.

Director Mark A. Welsh III of Northrop Grumman Corp. executed multiple sales of common stock on May 5, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Director Mark A. Welsh III of Northrop Grumman Corp. executed multiple sales of common stock on April 7, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Director Graham Robinson acquired 43 shares of Northrop Grumman common stock through a deferred stock unit account on March 31, 2025.

Director Arvind Krishna acquired 71 shares of Northrop Grumman common stock through the company's Long-Term Incentive Stock Plan on March 31, 2025.

Director Marianne Catherine Brown reports acquiring 90 shares of Northrop Grumman common stock through a deferred stock unit account and discloses total holdings of 10,190 shares.

Northrop Grumman's Chair, CEO, and President, Kathy J Warden, sold 3,750 shares of common stock at a price of $475.65 on March 6, 2025.

Director Mark A. Welsh III of Northrop Grumman Corp. executed multiple sales of common stock on March 5, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Benjamin R. Davies, CVP & President of Defense Systems at Northrop Grumman, sold 464 shares of common stock at $460.75 per share on February 28, 2025, under a pre-arranged trading plan.

Michael A. Hardesty, a Corporate VP, Controller & CAO at Northrop Grumman, sold 1,931 shares of common stock on February 24, 2025, at a price of $453.585 per share.

Kathryn G. Simpson, Corp VP & General Counsel of Northrop Grumman, reports selling 1,035 shares of common stock at $429.08 per share on February 20, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Benjamin R. Davies, a CVP & President of Defense Systems at Northrop Grumman, sold 192 shares of common stock at a price of $429.08 per share on February 20, 2025, under a pre-arranged 10b5-1 trading plan.

Kathy Warden, Chair, CEO, and President of Northrop Grumman, reports acquisition and disposal of common stock and derivative securities, including Restricted Performance Stock Rights (RPSRs) and Restricted Stock Rights (RSRs).

Kathryn G. Simpson, Corp VP & General Counsel of Northrop Grumman, reports acquisition and disposal of common stock and derivative securities, including restricted performance stock rights and restricted stock rights, under Rule 10b5-1 trading plan.

Roeder Roshan S., a CVP & President at Northrop Grumman, reports transactions involving common stock and derivative securities, including acquisitions and disposals related to restricted performance stock rights and restricted stock rights.

Thomas H. Jones, CVP & President of Aeronautics Systems at Northrop Grumman, reports acquisition and disposal of common stock and derivative securities, including Restricted Performance Stock Rights (RPSR) and Restricted Stock Rights (RSR).

Michael A. Hardesty, a Corporate VP, Controller & CAO at Northrop Grumman, reports transactions involving common stock and derivative securities, including the acquisition and disposal of shares and restricted stock rights.

Robert J. Fleming, CVP and President of Space Systems at Northrop Grumman, reports transactions involving common stock and derivative securities, including acquisitions and disposals of restricted performance stock rights and restricted stock rights.

Benjamin R. Davies, CVP & President of Defense Systems at Northrop Grumman, reports transactions involving common stock and derivative securities, including acquisitions, disposals, and vesting of restricted stock rights.

Kenneth B. Crews, CVP & Chief Financial Officer of Northrop Grumman, reports acquisition and disposal of common stock and restricted stock rights on February 18, 2025.

Director Mark A. Welsh III of Northrop Grumman Corp. executed multiple sales of common stock on February 5, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Northrop Grumman director Mark A. Welsh III sold a total of 33 shares of common stock on January 6, 2025, under a pre-arranged 10b5-1 trading plan.

Marianne Catherine Brown, a director at Northrop Grumman, acquired 99 shares of common stock through the company's long-term incentive plan.

Director Arvind Krishna acquired 77 shares of Northrop Grumman common stock through a long-term incentive plan.

Director Graham Robinson acquired 46 shares of Northrop Grumman stock through the company's long-term incentive plan.

Northrop Grumman director Mark A. Welsh III sold a total of 33 shares of common stock on December 5, 2024, under a pre-arranged 10b5-1 trading plan.

Northrop Grumman executive Benjamin R. Davies sold 1,156 shares of common stock at an average price of $532.93 per share on November 11, 2024, under a pre-arranged 10b5-1 trading plan.

Director Mark A. Welsh III of Northrop Grumman Corp. executed multiple sales of common stock on November 5, 2024, under a pre-arranged Rule 10b5-1 trading plan.